2022
DOI: 10.1007/978-981-16-9221-5_22
|View full text |Cite
|
Sign up to set email alerts
|

Computational Intelligence-Based Gene Expression Analysis in Colorectal Cancer: A Review

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
4
3

Relationship

0
7

Authors

Journals

citations
Cited by 8 publications
(3 citation statements)
references
References 71 publications
0
3
0
Order By: Relevance
“…To determine the potential target for the selected lead compound, the ChemMapper and PharmMapper server (http://www.lilab-ecust.cn/chemmapper/ and https://www.lilabecust.cn/pharmmapper/), respectively utilized (Trosset, 2019;Srivastava et al, 2022). The lead compound was submitted in sdf format, and the target set was limited to human targets while all other parameters were kept as default.…”
Section: Identification Of Targetmentioning
confidence: 99%
“…To determine the potential target for the selected lead compound, the ChemMapper and PharmMapper server (http://www.lilab-ecust.cn/chemmapper/ and https://www.lilabecust.cn/pharmmapper/), respectively utilized (Trosset, 2019;Srivastava et al, 2022). The lead compound was submitted in sdf format, and the target set was limited to human targets while all other parameters were kept as default.…”
Section: Identification Of Targetmentioning
confidence: 99%
“…Colorectal cancer (CRC) is one of the most common cancers, mainly due to alterations in genetic and epigenetic factors that lead to tumor progression and development [116,117]. Several NPs have been identified that play a significant role in stimulating various important signaling pathways, thus leading to CRC development [118].…”
Section: Emerging Neuropeptides Inhibitors In Colorectal Cancermentioning
confidence: 99%
“… 4 In addition, alterations such as mutations, chromosomal structural variants, microsatellite instability, gene fusions, altered gene expression, and epigenetic inactivation in cancer hallmark genes have been implicated in CRC development. 5 In the case of CRC, earlier studies have identified alterations in genes such as KRAS, NRAS, c-Myc, APC, TP53, CTNNB1, PIK3CA, and mismatch repair (MMR) genes with significant frequency in the number of CRC cases. 6 , 7 In recent years, researchers have also identified several new genes that serve as a potential therapeutic target (e.g., LGR4-6, RNF43, ZNRF3, RSPO2, ANO5, SLITRK1, NRXN1, and ANK2) and are linked to the CRC development.…”
Section: Introductionmentioning
confidence: 99%